Delhivery CEO Sahil Barua said ecommerce deliveries are leading the company’s growth. This and more in today’s ETtech Top 5.

NRIs view India with cautious optimism, recognizing its long-term growth potential despite recent market flatness and rupee depreciation. D...

Discover sattu, a traditional roasted flour, hailed by celebrity nutritionist Luke Coutinho as a potent remedy for numerous health woes. Th...

Startup founder's X post highlighted an international client's commitment to a paused six-month contract, contrasting it with India's often...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Indian IT firm Persistent Systems is making a significant move by launching a takeover bid for German digital engineering company Nagarro S...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Global crude oil prices fell sharply on Friday, with Brent slipping below $75 a barrel, as fears of supply disruptions through the Strait o...

Recent hikes in procurement price have provided little relief, according to stakeholders, as onion farmers argue that prices are still belo...

SpaceX shares have seen a significant drop, losing hundreds of billions in value over three days. This decline follows the company's announ...

Happy Monday! Byju's US lenders and Manipal are close to sealing a settlement over Aakash. This and more in today’s ETtech Morning Dispatch.

Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...